advances in oligometastatic disease - onctalk lung 2023
Published 3 months ago • 33 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
11:41
the adaura trial: flaws and results - leading developments & current questions in lung cancer
-
2:22
aegean trial: perioperative durvalumab for nsclc - onctalk lung 2023
-
2:22
q&a: what does monitoring look like after adjuvant chemotherapy? - onctalk lung 2023
-
6:43
what factors determine a successful clinical trial? - lung cancer onctalk 2022
-
0:13
the importance of biomarker testing- targeted therapies in lung cancer 2023- #shorts #youtubeshorts
-
3:26
q&a: what does lung cancer surgical recovery look like? - onctalk lung 2023
-
3:14
stereotactic body radiotherapy (sbrt) for oligoprogressive nsclc - onctalk lung 2023
-
0:31
biomarkers in nsclc - targeted therapies in lung cancer 2023 - #youtubeshorts #shorts
-
2:52
location of disease: can metastatic locations predict success of treatment? - onctalk 2022
-
2:32
segmentectomy for early stage nsclc - onctalk lung 2023
-
8:08
tumor treating fields for lung cancer - leading developments & current questions in lung cancer
-
5:48
teclistamab, talquetamab, and elranatamab: response rates and data - blood cancer onctalk 2023
-
3:25
checkmate 816: neoadjuvant nivolumab chemotherapy for nsclc - onctalk lung 2023
-
5:31
biomarkers in nsclc - targeted therapies in lung cancer 2023
-
1:59:57
grace - global resource for advancing cancer education live stream
-
2:57
lobar versus sublobar resection in nsclc - onctalk lung 2023
-
5:42
osimertinib and the flaura trial
-
10:02
gracecast-137_ca-101-_dr. ramalingam: q and a session on clinical trials in oncology
-
4:12
trials for patients with actionable mutations, & the importance of quality of life - onctalk 2022